News

Walgreens' decision to launch cell and gene therapy services comes after a surge in approvals of those drugs in the U.S. in the European Union over the last year. They are one-time, high-cost ...
Walgreens unveils its new Gene and Cell Services Pharmacy and Innovation Center– a dedicated 18,000-square-foot center in Pittsburgh, PA, with services and capabilities for these emerging ...
Walgreens Boots Alliance is now offering gene and cell therapy services alongside other changes to its specialty pharmacy business as it seeks to find efficiencies and boost revenues.
Bio-Techne will feature its cutting-edge advancements for cell and gene therapy development and manufacturing at booth 1537.
Starting January 1, 2026, Oregon will increase access to affordable, lifesaving cell and gene therapies for individuals on the Oregon Health Plan (OHP).
NewBiologix addresses gene therapy production limitations with its full suite of advanced cell lines for licensing as well as platform-based services.
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy ...
Walgreens Boots Alliance Inc. announced Thursday it has entered into a definitive agreement to be sold for $10 billion to private equity firm Sycamore Partners, which specializes in retail ...
Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access Blood centers are neutral partners, as they do not compete with hospitals for patients.
Investments include new Gene & Cell Services Pharmacy and Innovation Center DEERFIELD, Ill., May 13, 2024 /CSRwire/ - Walgreens is expanding its specialty pharmacy services and investing in its ...